5 Easy Facts About ABBV-744 combination therapy with chemotherapy Described
These side effects ended up notably milder as compared to an inhibitor of the two bromodomains. An in depth molecular Assessment also uncovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen Taylor88 These preclinical studies present paradigms for future clinical trials in AML, and the